Drug Discovery Services Market Forecast to 2030: Discover the Leading Strategic and Regional Growth Trends Major Players are Capitalizing On
30 août 2024 06h53 HE
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Drug Discovery Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Drug...
Leash Biosciences Announces $9.3 Million Seed Financing to Pioneer AI-Driven Medicinal Chemistry
05 avr. 2024 07h45 HE
|
Leash Biosciences
Leash Bio today announced the completion of a $9.3 million seed financing round and the launch of its inaugural machine learning Kaggle competition.
Unnatural Products, Inc. Enters Research Collaboration with Merck
23 janv. 2024 09h00 HE
|
Unnatural Products
Santa Cruz, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to enable the next generation of molecularly targeted therapeutics,...
Peter Madrid, Head of Scientific Discovery at Synfini, Joins Other Expert Speakers to Lead a National Academies of Sciences Workshop on AI for Scientific Discovery
11 oct. 2023 14h29 HE
|
Synfini
MENLO PARK, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Synfini, Inc., a pioneer in agile chemistry whose advanced, automated molecular discovery platform is transforming drug discovery, today...
Computer-Aided Drug Discovery Global Market Report 2022: Demand for Novel Drugs to Treat CVD Conditions Fuels Growth
07 nov. 2022 08h38 HE
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Computer-Aided Drug Discovery Market By Type, By Therapeutic Area, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report...
Artificial Intelligence In Drug Discovery Global Market Report 2022: Featuring Key Players IBM, Microsoft, Cloud Pharmaceuticals & Others
15 août 2022 04h38 HE
|
Research and Markets
Dublin, Aug. 15, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022, By Technology, By Drug Type, By Therapeutic Type, By End-Users" report has...
RxCelerate Launch RxNfinity™: A Next-Generation Machine Learning-Enabled Small Molecule Discovery Platform
19 juil. 2022 08h00 HE
|
RxCelerate
CAMBRIDGE, England, July 19, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international outsourced drug discovery and development platform, today revealed details of a new small molecule discovery...
Global Glycosylation Analysis Services Market, 2021-2030: Biopharmaceutical, Biomedical and Clinical Samples
13 sept. 2021 05h58 HE
|
Research and Markets
Dublin, Sept. 13, 2021 (GLOBE NEWSWIRE) -- The "Glycosylation Analysis Services Market by Company Size, Analytical Techniques and Key Geographical Regions: Industry Trends and Global Forecasts,...
Jubilant DraxImage receives approval from Health Canada for the RUBY Elution System™ (RbES) and proprietary RUBY™ Consumable Accessories
13 oct. 2017 11h29 HE
|
Jubilant DraxImage
Montreal, QC, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a Jubilant Pharma whollyowned subsidiary, is pleased to announce it has received approval from Health Canada...